Dr Sanjay Kalra
President of the Endocrine Society of India
We are all in the midst of a COVID-19 pandemic. Diabetes has been found to be apoor prognostic factor for COVID-19 infected people, but the reality is much deeper, diabetes has a multifaceted and bidirectional link with COVID-19.
Uncontrolled diabetes is a condition of impaired immunity. In an individual with poorly controlled diabetes, immunity may be impaired increasing susceptibility towards COVID-19 infections and worse outcomes if the person gets infected. Hence, diabetes can be considered a prognostic factor in COVID-19 infections.
Unfortunately, diabetes is considered as a tool for triage in many health systems in the world. It is important to counsel everybody involved that diabetes is a heterogeneous condition. Not everyone with diabetes will have poor outcomes. Certain factors are at play here including;
So, diabetes per se should not be viewed as a tool for triage. In fact it should be considered as a tool for improvement and achieving optimal targets. In this case, the target is recovery from COVID-19 infections.
Achieve and maintain euglycemia through lifestyle and appropriate drugs
Not every dysglycemia is diabetes, many people have stress hyperglycemia which needs to be identified and treated.
Glucovigilance: Health care professionals shouldbe very vigilant regarding the screening, diagnosis, management, and monitoring of dysglycemia
Don’t ignore other endocrine glands involved in critical conditions; adrenal insufficiency and thyroid syndrome
Adrenal insufficiency is quite common in ICU settings, presents as ‘Koala Bear syndrome,’ and health care personnel should work in teams including endocrinologists to identify and treat these endocrinal insufficiencies.
Health care team’s message to patients
Those who are not infected and those in confinement/lockdown
Symptomatic COVID-19 patients
You need to be hospitalized
You may need help from other health care personnel who might be an internist, intensivist or an infectious disease expert.
Follow their advice, manage optimal glucose levels. If glucose levels are very good, continue the same regimen. If glucose not controlled, an intensive insulin regimen may be needed.
Dr. Sanjay Kalra, MBBS, MD, DM (AIIMS New Delhi), is an endocrinologist based at Bharti Hospital, Karnal, India. An avid researcher, writer, and busy clinician, he is the past president of the Endocrine Society of India (ESI), President of the Indian Professional Association for Transgender Health (IPATH), President of the South Asian Federation of Endocrine Societies (SAFES), and Executive Committee member as well as Chair, Education Working Group at the International Society of Endocrinology (ISE). He is the Section Editor of Endo Text, the PubMed-indexed textbook. He serves as Editor-in-chief Asian Journal of Diabetology while offering his editorial skills to various other publications. Along with these and other responsibilities, he works to spread endocrine and diabetes awareness across the world. In his spare time, he indulges in his favorite hobbies, the folk-dance Bhangra and the traditional Indian club bell, 'Mugdar.'
Subscribe To Our Newsletter
Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please update your details
Please login to comment on this article